Aaron Ondrey
Finanzdirektor/CFO bei ROCKET PHARMACEUTICALS, INC.
Vermögen: 997 371 $ am 31.05.2024
Aktive Positionen von Aaron Ondrey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 26.03.2024 | - |
Karriereverlauf von Aaron Ondrey
Ehemalige bekannte Positionen von Aaron Ondrey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MIRATI THERAPEUTICS | Finanzdirektor/CFO | 08.09.2023 | 23.01.2024 |
| Corporate Officer/Principal | 01.07.2022 | 08.09.2023 | |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2010 | 01.11.2018 |
Ausbildung von Aaron Ondrey
| Case Western Reserve University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Aaron Ondrey
- Erfahrung